TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19607686

Group type: EXPERIMENTAL
Intervention: Balance training home exercise programme from a physiotherapist
Number of subjects: 214

Group type: COMPARATOR
Intervention: Education, information and support programme from an occupational therapist
Number of subjects: 214
Study: 18000962

Group type: EXPERIMENTAL
Intervention: Chronicle ICD group (hemodynamic monitoring system)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Control group (standard care without hemodynamic monitoring)
Number of subjects: 850
Study: 15521899

Group type: EXPERIMENTAL
Intervention: 200 microg salbutamol via pMDI + Volumatic
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 400 microg salbutamol via pMDI + Volumatic
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: salbutamol via pMDI + Volumatic
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: low dose salbutamol via pMDI + Volumatic
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: high dose salbutamol via Diskus
Number of subjects: 18
Study: 11134196

Group type: COMPARATOR
Intervention: Prednisone (5 mg orally, four times a day)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg orally, three times a day)
Number of subjects: 201
Study: 9662678

Group type: EXPERIMENTAL
Intervention: Primary care, practice-based physical activity behavioral interventions
Number of subjects: 874

Group type: COMPARATOR
Intervention: Standard care control condition
Number of subjects: 874
Study: 31760401

Group type: EXPERIMENTAL
Intervention: SLK triple therapy
Number of subjects: 240
Study: 28229548

Group type: EXPERIMENTAL
Intervention: Oligofructose (21 g for 12 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 37
Study: 26681629

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (525 mg for days 1-3, 1050 mg for day 4)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLACEBO)
Number of subjects: 18
Study: 24338654

Group type: EXPERIMENTAL
Intervention: FLESHD (frequent low-efficiency and short hemodialysis)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FLESHF (frequent low-efficiency and short hemofiltration)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FLESHD
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FLESHF
Number of subjects: 13
Study: 19726379

Group type: EXPERIMENTAL
Intervention: 100 mg flurbiprofen axetil (group F)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 10 ml intravenous saline (group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 17600040

Group type: EXPERIMENTAL
Intervention: Left ventricular hypertrophy (LVH)
Number of subjects: 7443

Group type: COMPARATOR
Intervention: No left ventricular hypertrophy (no LVH)
Number of subjects: 7443
Study: 15152708

Group type: EXPERIMENTAL
Intervention: Chestnut Health System's best‐practice Outpatient Treatment (CHS)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Cannabis Youth Treatment (CYT)
Number of subjects: 274
Study: 12473255

Group type: EXPERIMENTAL
Intervention: Fluvastatin 80 mg daily
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Fluvastatin treatment
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Fluvastatin treatment in patients with pronounced ischaemia
Number of subjects: 540
Study: 9726529

Group type: EXPERIMENTAL
Intervention: Computer-assisted prescription systems for anticoagulation management
Number of subjects: 1336

Group type: COMPARATOR
Intervention: Control group (standard anticoagulation management)
Number of subjects: 1336
Study: 8612436

Group type: EXPERIMENTAL
Intervention: Animal protein diet (APD) (protein intake 1.1 g · kg‐1 · day‐1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Vegetable protein diet (VPD) (protein intake 0.95 g · kg‐1 · day‐1)
Number of subjects: 9
Study: 2094145

Group type: EXPERIMENTAL
Intervention: 3mg PGE2 vaginal tablet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1mg PGE2 vaginal gel
Number of subjects: 24
Study: 111890

Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen (HBO)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Radiotherapy in air
Number of subjects: 82
Study: 30642657

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 13432

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13432
Study: 28266234

Group type: EXPERIMENTAL
Intervention: Desogestrel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 25845223

Group type: EXPERIMENTAL
Intervention: Acupuncture plus Lipitor (20 mg/tablet, one tablet per day for 6 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lipitor (20 mg/tablet, one tablet per day for 6 weeks)
Number of subjects: 60
Study: 22893038

Group type: EXPERIMENTAL
Intervention: 10 mg isoxsuprine tablets four times per day (Group A, n=15)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dexamethasone with hyaluronidase intralesional injections (Group B, n=15)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo tablets (Group C, n=10)
Number of subjects: 40
Study: 20537413

Group type: EXPERIMENTAL
Intervention: Peer mentoring (PM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Student mentoring (SM)
Number of subjects: 60
Study: 19285788

Group type: EXPERIMENTAL
Intervention: Retropubic sling procedure (IVS-02)
Number of subjects: 398

Group type: COMPARATOR
Intervention: Transobturator sling procedure (IVS-04)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 398
Study: 17484560

Group type: EXPERIMENTAL
Intervention: Frame-of-reference training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trained consultants with competency modeling experience
Number of subjects: 0
Study: 15340586

Group type: EXPERIMENTAL
Intervention: Computerized pain-management intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Distraction control group
Number of subjects: 120
Study: 11641307

Group type: EXPERIMENTAL
Intervention: L-arginine infusion in group A (n=27)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: L-arginine infusion in group B (n=18)
Number of subjects: 45

Group type: COMPARATOR
Intervention: L-arginine infusion in group C (n=11)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure monitoring in group B (n=18)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Group B (n=18)
Number of subjects: 45
Study: 9855336

Group type: EXPERIMENTAL
Intervention: Intravenous estradiol (various dosages)
Number of subjects: 8
Study: 7977406

Group type: EXPERIMENTAL
Intervention: Open-ended questionnaire
Number of subjects: 78

Group type: COMPARATOR
Intervention: Partly prompted questionnaire
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Detailed prompting questionnaire
Number of subjects: 78
Study: 2512462

Group type: EXPERIMENTAL
Intervention: Access to physician-fee information (experimental group)
Number of subjects: 1375

Group type: COMPARATOR
Intervention: Control group (no access to physician-fee information)
Number of subjects: 1375
Study: 30857904

Group type: EXPERIMENTAL
Intervention: Abduction brace (ABG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Open pouch arm sling (PASG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (ABG and PASG)
Number of subjects: 120
Study: 28754491

Group type: EXPERIMENTAL
Intervention: Recombinant human C1 esterase inhibitor twice weekly (50 IU/kg; maximum 4200 IU)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Recombinant human C1 esterase inhibitor once weekly (50 IU/kg; maximum 4200 IU)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 26546883

Group type: EXPERIMENTAL
Intervention: HP diet (32% protein, 33% carbohydrate, 30% fat)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Higher-carbohydrate diet (HC, 22% protein, 51% carbohydrate, 22% fat)
Number of subjects: 61
Study: 24304090

Group type: EXPERIMENTAL
Intervention: RFE under NMES
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: RFE
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (conventional arm rehabilitation programme without NMES)
Number of subjects: 27
Study: 22010226

Group type: EXPERIMENTAL
Intervention: Low-lipid (0.82%) food particles
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Normal-lipid (4.2%) food particles
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: High-lipid (15.7%) food particles
Number of subjects: 72

Group type: COMPARATOR
Intervention: Plastic grid floor (G)
Number of subjects: 72
Study: 19233758

Group type: EXPERIMENTAL
Intervention: Propofol (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Isoflurane (group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sevoflurane (group C)
Number of subjects: 60
Study: 17540212

Group type: EXPERIMENTAL
Intervention: Men with reduced ejection fraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Men with preserved ejection fraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Women with reduced ejection fraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Women with preserved ejection fraction
Number of subjects: 0
Study: 15225187

Group type: EXPERIMENTAL
Intervention: Ultrasound examination at 12-14 gestational weeks including risk assessment for Down's syndrome
Number of subjects: 2026

Group type: COMPARATOR
Intervention: Routine scan at 15-20 gestational weeks
Number of subjects: 2026
Study: 12111923

Group type: EXPERIMENTAL
Intervention: Handsearching
Number of subjects: 714

Group type: COMPARATOR
Intervention: MEDLINE searching
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Combination of handsearching and MEDLINE searching
Number of subjects: 714
Study: 9585275

Group type: EXPERIMENTAL
Intervention: 1% lidocaine (0.1 mL/kg) with 1:200,000 epinephrine (0.5 microg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atropine 0.01 mg/kg followed by test dose
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atropine followed by saline
Number of subjects: 60
Study: 7644960

Group type: EXPERIMENTAL
Intervention: Exercise therapy given by a physiotherapist
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo physiotherapy given by a physiotherapist
Number of subjects: 363

Group type: COMPARATOR
Intervention: Usual care by a general practitioner (information and analgesics)
Number of subjects: 363
Study: 2664882

Group type: EXPERIMENTAL
Intervention: Carbamazepine as a comedication to haloperidol (24 mg haloperidol p.d.)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Haloperidol alone (24 mg haloperidol p.d.)
Number of subjects: 20
Study: 559593

Group type: EXPERIMENTAL
Intervention: Chloramphenicol 50 mg/kg body-weight
Number of subjects: 100

Group type: COMPARATOR
Intervention: Epicillin 1 g six hourly
Number of subjects: 100
Study: 31838450

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 40
Study: 29688276

Group type: EXPERIMENTAL
Intervention: Active tDCS (20 min, 2 mA; n = 14)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham tDCS (n = 18)
Number of subjects: 32
Study: 26686932

Group type: EXPERIMENTAL
Intervention: Permuted locus trial design for randomized controlled trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Permuted locus trial
Number of subjects: 0
Study: 25161696

Group type: EXPERIMENTAL
Intervention: Panax ginseng (200 mg twice daily for four weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 22197630

Group type: EXPERIMENTAL
Intervention: Cognitive-sensorial stimuli to elicit CPD (CPD group, n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (n=19)
Number of subjects: 39
Study: 20495466

Group type: EXPERIMENTAL
Intervention: High-dose, extended-release mesalamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 0
Study: 19094598

Group type: EXPERIMENTAL
Intervention: Local anesthesia
Number of subjects: 269

Group type: COMPARATOR
Intervention: Epidural anesthesia
Number of subjects: 269
Study: 16144533

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11796769

Group type: EXPERIMENTAL
Intervention: Outreach treatment (mean of two sessions a week for 27.3 weeks)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Information provision (control group)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Outreach treatment
Number of subjects: 110
Study: 10518963

Group type: EXPERIMENTAL
Intervention: Trivastal 50 mg LP (doses increased to 150-250 mg/day)
Number of subjects: 113
Study: 7486602

Group type: EXPERIMENTAL
Intervention: Single doses of nimodipine (0, 30, 60 mg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Multiple daily doses of nimodipine (up to 150 mg in 12 hours)
Number of subjects: 25
Study: 2024732

Group type: EXPERIMENTAL
Intervention: Computer Interactive (CI)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Videotape (V)
Number of subjects: 126
Study: 6797752

Group type: EXPERIMENTAL
Intervention: Low-dose propranolol (40 mg every 6 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose propranolol (160 mg every 6 hours)
Number of subjects: 0
Study: 31907022

Group type: EXPERIMENTAL
Intervention: Verbal advice
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Traffic light (TL) risk card
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Quantitative light fluorescence (QLF) photograph
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Overall WTP
Number of subjects: 412
Study: 31476715

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 27271373

Group type: EXPERIMENTAL
Intervention: SST + IEMT
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: SST + sham IEMT + NMES
Number of subjects: 62

Group type: COMPARATOR
Intervention: SST
Number of subjects: 62
Study: 25492721

Group type: EXPERIMENTAL
Intervention: 8-week physical exercise programme (PEP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 25510692

Group type: EXPERIMENTAL
Intervention: Quinn's Advantage Cleavage and Blastocyst media (QAC/QAB)
Number of subjects: 159

Group type: COMPARATOR
Intervention: GIII series cleavage and blastocyst media (G1.3/G2.3)
Number of subjects: 159
Study: 22805855

Group type: EXPERIMENTAL
Intervention: Opuntia ficus-indica (OFI)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 6
Study: 19491817

Group type: EXPERIMENTAL
Intervention: Nootropil (piracetam) 100 mg/kg daily for 2 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nootropil (piracetam)
Number of subjects: 40
Study: 17211576

Group type: EXPERIMENTAL
Intervention: Basal levels of Hsp32, Hsp70, and Hsp90 in patients with inflammation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basal levels of Hsp32, Hsp70, and Hsp90 in controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of Hsp levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C-reactive protein and cytokines
Number of subjects: 0
Study: 15346756

Group type: EXPERIMENTAL
Intervention: Standard Brånemark System implants
Number of subjects: 12

Group type: COMPARATOR
Intervention: TiUnite Mk III implants
Number of subjects: 12
Study: 11518440

Group type: EXPERIMENTAL
Intervention: Weighted garments worn on the paretic side for six weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no weighted garments)
Number of subjects: 24
Study: 9715782

Group type: EXPERIMENTAL
Intervention: Lisinopril (10, 20, or 40 mg/day)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) (12.5, 25, or 50 mg/day)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 124
Study: 8009196

Group type: EXPERIMENTAL
Intervention: Casodex 50 mg p.o. daily for seven to 12 months
Number of subjects: 5
Study: 3066086

Group type: EXPERIMENTAL
Intervention: Penbutolol (40 mg/day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Propranolol (160 mg/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Penbutolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 8
Study: 30837426

Group type: EXPERIMENTAL
Intervention: AOM group (n=31)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: COME group (n=39)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (n=37)
Number of subjects: 107
Study: 27364322

Group type: EXPERIMENTAL
Intervention: Oral teriflunomide
Number of subjects: 324

Group type: COMPARATOR
Intervention: Subcutaneous interferon beta‐1a
Number of subjects: 324
Study: 26319218

Group type: EXPERIMENTAL
Intervention: Active assistive forced exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Passive assistive forced exercise
Number of subjects: 24
Study: 23146571

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Closed reduction
Number of subjects: 22
Study: 16773696

Group type: EXPERIMENTAL
Intervention: Glivec (imatinib mesylate)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Not treated with Glivec (group A)
Number of subjects: 74
Study: 14609783

Group type: EXPERIMENTAL
Intervention: Intravenous phytonadione (0.5 mg for INR 6-10; 1 mg for INR >10)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Oral phytonadione (2.5 mg for INR 6-10; 5 mg for INR >10)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Intravenous phytonadione
Number of subjects: 61

Group type: COMPARATOR
Intervention: Oral phytonadione
Number of subjects: 61
Study: 10577849

Group type: EXPERIMENTAL
Intervention: ICE chemotherapy (ifosfamide, carboplatin, etoposide)
Number of subjects: 163
Study: 8712561

Group type: EXPERIMENTAL
Intervention: ARROWgard catheter
Number of subjects: 191

Group type: COMPARATOR
Intervention: Standard triple lumen catheter
Number of subjects: 191
Study: 1861632

Group type: EXPERIMENTAL
Intervention: No calcium fluid (ionized calcium 0 mmol/L)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control fluid (ionized calcium 1.25 mmol/L)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: No magnesium fluid (ionized magnesium 0 mmol/L)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: No albumin fluid (albumin 0 g/L)
Number of subjects: 6
Study: 6226601

Group type: EXPERIMENTAL
Intervention: Cimetidine, 1 g orally for 28 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31286729

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with hyperbaric oxygen (HBO) therapy, treatment given once every day for 6 courses (5 days on, 2 days off).
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional therapy combined with HBO (control group).
Number of subjects: 26
Study: 28317428

Group type: EXPERIMENTAL
Intervention: Complete revascularization of non-infarct-related coronary arteries guided by fractional flow reserve (FFR), 295 patients
Number of subjects: 885

Group type: COMPARATOR
Intervention: No revascularization of non-infarct-related coronary arteries, 590 patients
Number of subjects: 885
Study: 26266376

Group type: COMPARATOR
Intervention: Sufentanil (0.02 μg/kg/h)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sufentanil plus dexmedetomidine (0.02 μg/kg/h each, Group D1)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Sufentanil (0.02 μg/kg/h) plus dexmedetomidine (0.04 μg/kg/h, Group D2)
Number of subjects: 132
Study: 24340314

Group type: EXPERIMENTAL
Intervention: Standard triple therapy (PPI-CA) with rabeprazole (20 mg), clarithromycin (500 mg), and amoxicillin (1 g) for 10 days.
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Sequential therapy (ST) with amoxicillin (1 g) on days 1 to 5, and metronidazole (500 mg) and clarithromycin (500 mg) on days 6 to 10.
Number of subjects: 104
Study: 21630179

Group type: EXPERIMENTAL
Intervention: Baby sleeping bag
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional bedding
Number of subjects: 15
Study: 19803576

Group type: EXPERIMENTAL
Intervention: COMET + therapy as usual (TAU)
Number of subjects: 52

Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 52
Study: 16166239

Group type: EXPERIMENTAL
Intervention: Submaximal exercise bout
Number of subjects: 15
Study: 15273913

Group type: EXPERIMENTAL
Intervention: Sheridan-Gardiner test (SGT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Räder test (RT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Examination duration SGT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Examination duration RT
Number of subjects: 30
Study: 11394984

Group type: EXPERIMENTAL
Intervention: Community risk-reduction campaign and distribution of female condoms and male condoms at Intervention sites.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Community risk-reduction campaign with male condoms only at Control sites.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Female condom distribution at Intervention sites.
Number of subjects: 12
Study: 9086380

Group type: EXPERIMENTAL
Intervention: Neuro-PID controller with quadriceps stimulation
Number of subjects: 2

Group type: COMPARATOR
Intervention: PID feedback controller
Number of subjects: 2
Study: 7690165

Group type: EXPERIMENTAL
Intervention: Aprotinin (high-dosage Trasylol scheme)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2440683

Group type: EXPERIMENTAL
Intervention: aprindine 2 mg kg‐1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: sotalol 1.5 mg kg‐1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: aprindine 1 mg kg‐1 & sotalol 0.75 mg kg‐1
Number of subjects: 12
Study: 29423258

Group type: EXPERIMENTAL
Intervention: Social identity group management intervention delivered by COPD rehabilitation staff
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 27412590

Group type: EXPERIMENTAL
Intervention: Bromelain (1,050 mg/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (starch-filled capsules)
Number of subjects: 68
Study: 25787199

Group type: EXPERIMENTAL
Intervention: 30 months of dual antiplatelet therapy (continued thienopyridine)
Number of subjects: 11648

Group type: COMPARATOR
Intervention: 12 months of dual antiplatelet therapy (placebo)
Number of subjects: 11648